Sandra Silvestri MD, PhD | Ipsen Leadership
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership
  4. Sandra Silvestri, M.D., Ph.D.

Sandra Silvestri, M.D., Ph.D.

Back
Sandra Silvestri, M.D., Ph.D.

Sandra Silvestri, M.D., Ph.D.

  • Executive Vice President,
  • Chief Medical Officer
  • Follow in LinkedIn

Ipsen Chief Medical Officer

Sandra Silvestri, M.D., Ph.D.,  joined Ipsen in 2023 as Executive Vice President, Chief Medical Officer and heading Global Medical Affairs, Patient Safety and Patient Affairs.

Prior to joining Ipsen, Sandra held multiple leadership roles at Sanofi, where she was most recently SVP Global Medical Head for General Medicine GBU, leading a team of 1,600 medical employees worldwide. She also held several leadership positions at Eli Lilly in multiple disease areas including diabetology, endocrinology, neuroscience, immunology, dermatology, and oncology.

Medical doctor, specialized in Endocrinology and Metabolic diseases, she holds a PhD in internal medicine and cardiovascular diseases and a Master II in pharmacogenetics. She has been an investigator in several clinical studies, published numerous book chapters as well as scientific articles in international journals, been a speaker in several national and international congresses, and from 2017 to April 2023 she has led the Gender Balance Board and Global Network at Sanofi. She stays active as a professor at the medical schools of the University of Florence, Italy, and Descartes University in Paris. She has lived in Italy, Denmark, USA, France, and speaks Italian, English and French.

Related stories

A Life in Science: Navigating Uncertainty to Make a Difference 
24 February 2025 1 mins read

A Life in Science: Navigating Uncertainty to Make a Difference 

Partnering for Progress: The Importance of Collaboration in Primary Biliary Cholangitis (PBC) Awareness  
12 September 2024 4 mins read

Partnering for Progress: The Importance of Collaboration in Primary Biliary Cholangitis (PBC) Awareness  

Exploring life and parenthood with Primary Biliary Cholangitis 
20 May 2024 4 mins read

Exploring life and parenthood with Primary Biliary Cholangitis 

IPN price

€103.00

 €-0.70 (-0.68%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue